跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CLONIDINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CLONIDINE
Authorized
STANDARD
CLONIDINE
sivem pharmaceuticals ulc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
c6319ae615dc1ce3
Company
sivem pharmaceuticals ulc
Type
Standard
Approval Details
Approval Id
c6319ae615dc1ce3
Drug Approval Canada Name
CLONIDINE
Product Name
CLONIDINE
Status
Marketed
Status Date
2024-02-02
Original Market Date
2024-02-02
Din
02538504
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:08.16
Atc Original
C02AC01 CLONIDINE
Atc Name
c 02 ac 01
Aig Number
0108891002
Company Name
sivem pharmaceuticals ulc
Company Address
4705 Dobrin Street, Saint-Laurent, Quebec, Canada, H4R 2P7
Active Ingredients
CLONIDINE HYDROCHLORIDE
0.2 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
c6319ae615dc1ce3
Type
Standard
Back to Health Canada Approvals